|
1
|
Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA.
|
Carcinogenesis
|
2012
|
1.01
|
|
2
|
Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumors.
|
Clin Cancer Res
|
2014
|
0.99
|
|
3
|
Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
|
Breast Cancer Res Treat
|
2007
|
0.86
|
|
4
|
Neurotensin, a novel target of Wnt/β-catenin pathway, promotes growth of neuroendocrine tumor cells.
|
Int J Cancer
|
2014
|
0.82
|
|
5
|
The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BON.
|
Anticancer Res
|
2011
|
0.81
|
|
6
|
Novel small interfering RNA cotargeting strategy as treatment for colorectal cancer.
|
Surgery
|
2012
|
0.79
|